We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$705M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CVS Health
CVS
$133B
| $226M | 0.24% |
2,357,797
-1,467,579
| -38% | -$146M |
|
77
Tyson Foods
TSN
$20.4B
| $224M | 0.24% |
3,353,677
-268,951
| -7% | -$17.4M |
|
78
Eaton
ETN
$161B
| $224M | 0.24% |
3,748,354
-302,187
| -7% | -$18.6M |
|
79
Target
TGT
$65.6B
| $223M | 0.24% |
3,189,467
+145,334
| +5% | +$10.8M |
|
80
PUT
Procter & Gamble
PG
$336B
| $220M | 0.23% |
2,595,000
+1,411,200
| +119% | +$116M |
|
|
CA
81
DELISTED
CA, Inc.
CA
| $216M | 0.23% |
6,570,979
-2,436,101
| -27% | -$76.2M |
|
82
McDonald's
MCD
$192B
| $215M | 0.23% |
1,784,095
+521,955
| +41% | +$65.4M |
|
83
Broadcom
AVGO
$1.85T
| $214M | 0.23% |
13,774,950
+1,209,050
| +10% | +$18.4M |
|
84
SLB Ltd
SLB
$73.6B
| $213M | 0.23% |
2,691,974
+79,682
| +3% | +$6.11M |
|
85
PUT
JPMorgan Chase
JPM
$935B
| $212M | 0.23% |
3,414,000
+2,205,100
| +182% | +$138M |
|
86
Bristol-Myers Squibb
BMY
$133B
| $212M | 0.23% |
2,880,470
-885,399
| -24% | -$62.6M |
|
87
PUT
GE Aerospace
GE
$374B
| $211M | 0.22% |
1,398,725
+821,190
| +142% | +$120M |
|
|
FITB
88
Fifth Third Bancorp
FITB
$51.2B
| $209M | 0.22% |
11,862,773
-4,649,080
| -28% | -$83.4M |
|
|
CELG
89
DELISTED
Celgene Corp
CELG
| $207M | 0.22% |
2,102,870
-21,304
| -1% | -$2.2M |
|
|
ATVI
90
DELISTED
Activision Blizzard
ATVI
| $207M | 0.22% |
5,222,638
+1,046,208
| +25% | +$38.4M |
|
91
Celanese
CE
$4.9B
| $207M | 0.22% |
3,161,169
-696,712
| -18% | -$48.4M |
|
92
Mattel
MAT
$4.38B
| $206M | 0.22% |
6,598,293
-864,016
| -12% | -$27.4M |
|
93
Biogen
BIIB
$30B
| $206M | 0.22% |
849,872
-8,680
| -1% | -$2.29M |
|
|
94
General Dynamics
GD
$104B
| $203M | 0.22% |
1,459,233
+1,364,643
| +1,443% | +$190M |
|
95
TotalEnergies
TTE
$195B
| $200M | 0.21% |
4,168,059
-1,081,264
| -21% | -$51.8M |
|
96
UBS Group
UBS
$173B
| $200M | 0.21% |
15,472,787
-12,157,447
| -44% | -$186M |
|
97
Ryder
R
$9.83B
| $197M | 0.21% |
3,226,472
-630,321
| -16% | -$41.7M |
|
|
AET
98
DELISTED
Aetna Inc
AET
| $193M | 0.21% |
1,580,376
-16,423
| -1% | -$1.89M |
|
99
Bank of America
BAC
$435B
| $192M | 0.2% |
14,491,337
-938,875
| -6% | -$13.2M |
|
100
PUT
Home Depot
HD
$331B
| $192M | 0.2% |
1,505,900
+923,200
| +158% | +$122M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.